Found 8 matching trials
Influence of Ubrogepant and Sumatriptan on the Dermal Blood Flow Response to Histamine, Cinnamaldehyde and Capsaicin
NAThe involvement of calcitonin gene-related peptide (CGRP) in the cinnamalde...
Location
Center for Clinical Pharmacology
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007)
PHASE2The purpose of this study is to characterize the pharmacokinetics of MK-160...
Location
Multiple Locations
An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine
PHASE3This study will evaluate the long-term safety and tolerability of intermitt...
Location
Radiant Research, Inc.
Ubrogepant treatmeNt in mIgraine Patients Utilizing mOnoclonal aNtibodies
PHASE4This is a prospective open-label randomized study assessing similar endpoin...
Status
Active Not Recruiting
Location
Chicago Headache Center & Research Institute
Safety, Tolerability and Drug- Drug Interaction Study of Ubrogepant With Erenumab or Galcanezumab in Participants With Migraine
PHASE1This study will evaluate the potential for a pharmacokinetic (PK) interacti...
Study to Evaluate Oral Ubrogepant in the Acute Treatment of Migraine During the Prodrome in Adult Participants
PHASE3Study to Evaluate the Efficacy, Safety, and Tolerability of Oral Ubrogepant...
Location
Achieve Clinical Research, LLC /ID# 237098
Efficacy, Safety, and Tolerability Study of Oral Ubrogepant in the Acute Treatment of Migraine
PHASE3This study will evaluate the efficacy, safety, and tolerability of 2 doses ...
Location
Clinical Research Advantage, Inc./Desert Clinical Research, LLC.
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006)
PHASE2The purpose of this study is to assess the effectiveness, safety and tolera...
Location
Multiple Locations